Close

Pre-Open Stock Movers 04/09: (CELC) (AFMD) (GLSI) Higher; (PRVB) (ITRM) (JKS) Lower (more...)

Go back to Pre-Open Stock Movers 04/09: (CELC) (AFMD) (GLSI) Higher; (PRVB) (ITRM) (JKS) Lower (more...)

Greenwich LifeSciences (GLSI) Reports Poster Publication of Final 5-Yr GP2 Phase IIb Clinical Trial Immune Response Data

April 12, 2021 6:14 AM EDT

Greenwich LifeSciences, Inc. (NASDAQ: GLSI) (the Company), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today presented a poster of the final 5 year GP2 Phase IIb clinical trial immune response data at the 2021 AACR Annual Meeting. Immune response is the primary mechanism of action for GP2 and is critical to developing dosing and booster treatment strategies that are designed to achieve and sustain peak immunity, as well as to prevent metastatic breast cancer recurrences.

It has been... More

fuboTV Inc. (FUBO) Extends Gain, Up 15%

April 9, 2021 10:44 AM EDT

fuboTV Inc. (NYSE: FUBO) Extends Gain, Up 15%

... More